| scholarly article | Q13442814 |
| P50 | author | Erhe Gao | Q38137327 |
| P2093 | author name string | Walter J Koch | |
| Yajing Wang | |||
| Lawrence Chan | |||
| Hangxiang Zhang | |||
| Wayne B Lau | |||
| Ling Tao | |||
| Yuexing Yuan | |||
| Xin L Ma | |||
| P2860 | cites work | Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes | Q22250883 |
| Oxidant stress impairs in vivo reendothelialization capacity of endothelial progenitor cells from patients with type 2 diabetes mellitus: restoration by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone | Q80528293 | ||
| Pioglitazone ameliorates endothelial dysfunction and restores ischemia-induced angiogenesis in diabetic mice | Q80782848 | ||
| Myocardial infarction in diabetic rats: role of hyperglycaemia on infarct size and early expression of hypoxia-inducible factor 1 | Q28568891 | ||
| Increased beta -oxidation but no insulin resistance or glucose intolerance in mice lacking adiponectin | Q28588020 | ||
| Troglitazone inhibits atherosclerosis in apolipoprotein E-knockout mice: pleiotropic effects on CD36 expression and HDL. | Q32085397 | ||
| Adiponectin protects against myocardial ischemia-reperfusion injury through AMPK- and COX-2-dependent mechanisms | Q33688706 | ||
| Peroxisome proliferator-activated receptors (PPARs): nuclear receptors at the crossroads between lipid metabolism and inflammation | Q34088380 | ||
| ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism | Q34537657 | ||
| Long-term risk of cardiovascular events with rosiglitazone: a meta-analysis | Q34686103 | ||
| Pathophysiologic role of myocardial apoptosis in post-infarction left ventricular remodeling. | Q34972837 | ||
| Diabetes mellitus and heart failure. | Q35162693 | ||
| The variation of plasma concentrations of a novel, adipocyte derived protein, adiponectin, in patients with acute myocardial infarction | Q35581179 | ||
| Obesity, adiponectin and vascular inflammatory disease | Q35587168 | ||
| Adiponectin protects against the development of systolic dysfunction following myocardial infarction. | Q36004798 | ||
| Pharmacokinetics of the potent redox-modulating manganese porphyrin, MnTE-2-PyP(5+), in plasma and major organs of B6C3F1 mice | Q36973998 | ||
| Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning. | Q37019662 | ||
| Thiazolidinediones: do harms outweigh benefits? | Q37032628 | ||
| Adiponectin translation is increased by the PPARgamma agonists pioglitazone and omega-3 fatty acids | Q37138726 | ||
| Peroxisome proliferator-activated receptor gamma ligands inhibit development of atherosclerosis in LDL receptor-deficient mice | Q37242527 | ||
| Cardioprotective effects of thioredoxin in myocardial ischemia and reperfusion: role of S-nitrosation [corrected]. | Q37388923 | ||
| Mice lacking adiponectin show decreased hepatic insulin sensitivity and reduced responsiveness to peroxisome proliferator-activated receptor gamma agonists | Q38318111 | ||
| Ligands of the peroxisome proliferator-activated receptors (PPAR-gamma and PPAR-alpha) reduce myocardial infarct size | Q40721892 | ||
| Induction of adipocyte complement-related protein of 30 kilodaltons by PPARgamma agonists: a potential mechanism of insulin sensitization | Q42818292 | ||
| Adiponectin mediates the suppressive effect of rosiglitazone on plasminogen activator inhibitor-1 production | Q42823673 | ||
| PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein | Q42826174 | ||
| Pivotal role of a gp91(phox)-containing NADPH oxidase in angiotensin II-induced cardiac hypertrophy in mice. | Q43862772 | ||
| Potentiation of insulin signaling in tissues of Zucker obese rats after acute and long-term treatment with PPARgamma agonists | Q44080989 | ||
| Antioxidative, Antinitrative, and Vasculoprotective Effects of a Peroxisome Proliferator–Activated Receptor-γ Agonist in Hypercholesterolemia | Q44650457 | ||
| Effect of rosiglitazone on common carotid intima-media thickness progression in coronary artery disease patients without diabetes mellitus | Q44786820 | ||
| Anti-apoptotic effects of rosiglitazone in hypercholesterolemic rabbits subjected to myocardial ischemia and reperfusion | Q44801120 | ||
| Plasma adiponectin levels and risk of myocardial infarction in men. | Q44843420 | ||
| Rosiglitazone, but not glimepiride, improves myocardial diastolic function in association with reduction in oxidative stress in type 2 diabetic patients without overt heart disease | Q46287219 | ||
| Peroxisome proliferator-activated receptor-gamma agonist rosiglitazone reduces clinical inflammatory responses in type 2 diabetes with coronary artery disease after coronary angioplasty | Q46475289 | ||
| Different effect of acute treatment with rosiglitazone on rat myocardial ischemia/reperfusion injury by administration method | Q46525414 | ||
| Beneficial effects of rosiglitazone on novel cardiovascular risk factors in patients with Type 2 diabetes mellitus | Q46728070 | ||
| Rosiglitazone and carotid IMT progression rate in a mixed cohort of patients with type 2 diabetes and the insulin resistance syndrome: main results from the Rosiglitazone Atherosclerosis Study. | Q51477941 | ||
| Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. | Q51555890 | ||
| Acute myocardial infarction in dogs with experimental diabetes | Q72722176 | ||
| Association of hypoadiponectinemia with coronary artery disease in men | Q78780687 | ||
| Cardioprotection: nitric oxide, protein kinases, and mitochondria | Q79780264 | ||
| Adiponectin cardioprotection after myocardial ischemia/reperfusion involves the reduction of oxidative/nitrative stress | Q79880676 | ||
| P433 | issue | 2 | |
| P921 | main subject | myocardial infarction | Q12152 |
| (RS)-rosiglitazone | Q424771 | ||
| P304 | page(s) | 409-417 | |
| P577 | publication date | 2009-11-25 | |
| P1433 | published in | Circulation Research | Q2599020 |
| P1476 | title | Adiponectin: an indispensable molecule in rosiglitazone cardioprotection following myocardial infarction | |
| P478 | volume | 106 |
| Q37688767 | 2,3,5,4'-Tetrahydroxystilbene-2-O-β-D-glucoside protects murine hearts against ischemia/reperfusion injury by activating Notch1/Hes1 signaling and attenuating endoplasmic reticulum stress |
| Q34423842 | A novel and efficient model of coronary artery ligation and myocardial infarction in the mouse |
| Q35971216 | Adiponectin action: a combination of endocrine and autocrine/paracrine effects. |
| Q35859734 | Adiponectin and cardiovascular health: an update |
| Q26821925 | Adiponectin as a potential biomarker of vascular disease |
| Q35408342 | Adiponectin fine-tuning of liver regeneration dynamics revealed through cellular network modeling |
| Q54350766 | Adiponectin regulates SR Ca(2+) cycling following ischemia/reperfusion via sphingosine 1-phosphate-CaMKII signaling in mice. |
| Q39502711 | Atrial natriuretic peptide induces peroxisome proliferator activated receptor γ during cardiac ischemia-reperfusion in swine heart. |
| Q83398883 | Blood pressure decrease with ingestion of a soya product (kinako) or fish oil in women with the metabolic syndrome: role of adiponectin and nitric oxide |
| Q45247800 | Cardiac-derived adiponectin induced by long-term insulin treatment ameliorates myocardial ischemia/reperfusion injury in type 1 diabetic mice via AMPK signaling |
| Q38739373 | Caveolin-3 plays a critical role in autophagy after ischemia-reperfusion |
| Q54387449 | Changes in adiponectin expression in acute myocardial infarction rats and the significance of bisoprolol intervention. |
| Q47372080 | Effect of rosiglitazone on cardiac electrophysiology, infarct size and mitochondrial function in ischaemia and reperfusion of swine and rat heart. |
| Q47660438 | Effects of age and exercise training on coronary microvascular smooth muscle phenotype and function |
| Q33642616 | Fenofibrate promotes ischemia-induced revascularization through the adiponectin-dependent pathway |
| Q35131524 | Fish oil N-3 fatty acids increase adiponectin and decrease leptin levels in patients with systemic lupus erythematosus |
| Q35889770 | Fish oil decreases inflammation and reduces cardiac remodeling in rosiglitazone treated aging mice |
| Q34438892 | Globular adiponectin protects H9c2 cells from palmitate-induced apoptosis via Akt and ERK1/2 signaling pathways |
| Q33892702 | Globular adiponectin, acting via AdipoR1/APPL1, protects H9c2 cells from hypoxia/reoxygenation-induced apoptosis |
| Q26865140 | Hypoadiponectinaemia in diabetes mellitus type 2: molecular mechanisms and clinical significance |
| Q38317335 | Impaired mitochondrial biogenesis due to dysfunctional adiponectin-AMPK-PGC-1α signaling contributing to increased vulnerability in diabetic heart |
| Q46923821 | Increased myocardial ischemia-reperfusion injury in renal failure involves cardiac adiponectin signal deficiency |
| Q43498079 | Intervention of rosiglitazone on myocardium Glut-4 mRNA expression during ischemia-reperfusion injury in cardio-pulmonary bypass in dogs |
| Q58788939 | Liver-heart crosstalk controls IL-22 activity in cardiac protection after myocardial infarction |
| Q44797718 | Mechanisms responsible for beneficial and adverse effects of rosiglitazone in a rat model of acute cardiac ischaemia-reperfusion. |
| Q47924477 | Melatonin protects against the pathological cardiac hypertrophy induced by transverse aortic constriction through activating PGC-1β: In vivo and in vitro studies. |
| Q54335751 | Melatonin receptor-mediated protection against myocardial ischemia/reperfusion injury: role of SIRT1. |
| Q41672070 | Metformin in combination with rosiglitazone contribute to the increased serum adiponectin levels in people with type 2 diabetes mellitus |
| Q26784504 | N-3 Polyunsaturated Fatty Acids and Inflammation in Obesity: Local Effect and Systemic Benefit |
| Q35896190 | Obesity and pulmonary arterial hypertension: Is adiponectin the molecular link between these conditions? |
| Q34689526 | PPAR agonist-induced reduction of Mcp1 in atherosclerotic plaques of obese, insulin-resistant mice depends on adiponectin-induced Irak3 expression |
| Q26771753 | PPARs: Protectors or Opponents of Myocardial Function? |
| Q39740098 | PPARγ activator, rosiglitazone: Is it beneficial or harmful to the cardiovascular system? |
| Q45771801 | Peroxisome-proliferator-activated receptor γ mediates the second window of anaesthetic-induced preconditioning |
| Q35025858 | Pleiotropic effects of glitazones: a double edge sword? |
| Q42219850 | Protective effect of rosiglitazone on kidney function in high-fat challenged human-CRP transgenic mice: a possible role for adiponectin and miR-21? |
| Q28116438 | Regulation of Abro1/KIAA0157 during myocardial infarction and cell death reveals a novel cardioprotective mechanism for Lys63-specific deubiquitination |
| Q38216032 | Role of adiponectin in metabolic and cardiovascular disease |
| Q91638894 | Rosiglitazone alleviates myocardial apoptosis in rats with acute myocardial infarction via inhibiting TLR4/NF-κB signaling pathway |
| Q58803671 | Rosiglitazone augments antioxidant response in the human trophoblast and prevents apoptosis† |
| Q41858907 | Sevoflurane preconditioning attenuates myocardial ischemia/reperfusion injury via caveolin-3-dependent cyclooxygenase-2 inhibition |
| Q36203979 | Short-Term Therapy with Rosiglitazone, a PPAR-γ Agonist, Improves Metabolic Profile and Vascular Function in Nonobese Lean Wistar Rats |
| Q36953381 | Suppression of oxidative stress in endothelial progenitor cells promotes angiogenesis and improves cardiac function following myocardial infarction in diabetic mice |
| Q38915167 | The evolving role of adiponectin as an additive biomarker in HFrEF. |
| Q37926558 | The potential effects of anti-diabetic medications on myocardial ischemia-reperfusion injury |
| Q34571736 | The role of adipose tissue in mediating the beneficial effects of dietary fish oil |
| Q37166684 | Tongxinluo Improves Cardiac Function and Ameliorates Ventricular Remodeling in Mice Model of Myocardial Infarction through Enhancing Angiogenesis |
Search more.